___

• 1. Bacigalupo A, Giordano D, Vanlint MT, Vinercati R, Marmont AM, Martino OS. Bolus methylprednisolone in severe aplastic anemia. N Engl J Med 1979; 300: 502.
• 2. Özsoylu fi, Coflkun T, M›nassazi S. High–dose intravenous glucocorticoid in the treatment of childhood acquired aplastic anemia. Scand J Haematol 1984; 33: 309-316.
• 3. Özsoylu fi. High-dose intravenous methylprednisolone (HIVMP) in hematologic disorders. Hematology Reviews 1990; 4: 197-207.
• 4. Özsoylu fi. High-dose intravenous corticosteroid treatment for patients with Diamond-Blackfan syndrome refractory to classical prednisone treatment. Acta Haematol 1984; 71: 207-210.
• 5. Özsoylu fi. High-dose intravenous corticosteroid treatment for patients with Diamond-Blackfan syndrome resistant or refractory to conventional treatment. Am J Ped Hematol Oncol 1988; 10: 217-223.
• 6. Bernini JC, Carillo JM, Buchanon GR. High dose intravenous methylprednisolone therapy for patients with Diamond-Blackfan anemia refractory to conventional doses of prednisone. J Pediatr 1995; 127: 654-659.
• 7. Özsoylu fi. Bolus methylprednisolone therapy for chronic idiopathic thrombocytopenic purpura in children. Acta Haematol 1984; 72: 359.
• 8. Özsoylu fi. High-dose intravenous methylprednisolone for chronic idiopathic thrombocytopenic purpura. Acta Haematol 1989; 81: 112-113.
• 9. Özsoylu Ş. İrken G, Karabent A. High-dose intravenous methylprednisolone for acute childhood idiopathic thrombocytopenic purpura. Eur J Haematol 1989; 42: 431-435.
• 10. Özsoylu Ş. Megadose methylprednisolone for childhood idiopathic thrombocytopenic purpura (ITP). Turk J Med Sci 2005; 35: 347- 356.
• 11. Hiçsönmez G, Özsoylu Ş, Tuncer M, Erer B. High-dose intravenous methylprednisolone in the treatment of acute nonlymphoblastic leukemia with ocular involvement. Turk J Pediatr 1988; 30: 181-183.
• 12. Hiçsönmez G, Özsoylu Ş, Gürgey A, Zamani VP, İrken G. High dose methylprednisolone for remission induction in children with acute non-lymphoblastic leukemia. Eur J Haematol 1989; 42: 498-500.
• 13. Hiçsönmez G, Onat N, Albayrak D, Yetgin S, Özsoylu Ş. Acceleration of leukocyte recovery on short-course high-dose methylprednisolone in children with acute lymphoblastic leukemia. Pediatr Hematol Oncol 1991; 8: 193-197.
• 14. Hiçsönmez G, Özsoylu Ş, Onat N et al. High–dose methylprednisolone in resistant and relapsed children with acute lymphoblastic leukemia. Medical Pediatr Oncol 1994; 22: 68-69.
• 15. Özsoylu Ş, Ruacan Ş. High-dose bolus methylprednisolone treatment for primary myelofibrosis. Eur J Pediat 1983; 140: 810.
• 16. Özsoylu Ş, Bilgin K. Megadose methylprednisolone for the treatment of thrombotic thrombocytopenic purpura. Tur J Med Sci 1993; 22: 129-130.
• 17. Yetgin S, Özsoylu fi. Comparison of megadose methylprednisolone versus conventional dose methylprednisolone in hematologic disorders. J Pediatr Hematol Oncol 2007; 29: 253-259.
• 18. Özsoylu Ş, İrken G, Gürgey A. High–dose intravenous methylprednisolone for Kasabach-Merritt syndrome. Eur J Pediatr 1989; 148: 403-405.
• 19. Özsoylu Ş, Ertürk G. Oral megadose methylprednisolone for childhood acute idiopathic thrombocytopenic purpura. Blood 1991; 77: 1856-1857.
• 20. Kurtoğlu S, Üzüm K, Özdemir MA, Patıroğlu T. Megadose methylprednisolone tedavisi surrenal supresyonu yapıyor mu ? Yeni Tıp Dergisi 1996; 113: 256-257.
• 21. Özsoylu Ş. Nose drops and common cold. Eur J Pediatr 1985;144: 294.